Sharekhan

Anuh Pharma Ltd

Fri 22/05/2026,15:46:48 | NSE : ANUHPHR

₹ 75.58-0.59 (-0.77%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 78.00

Previous Close

₹ 76.17

Volume

60239

Mkt Cap ( Rs. Cr)

₹757.49

High

₹ 78.00

Low

₹ 75.00

52 Week High

₹ 114.90

52 Week Low

₹ 67.00

Book Value Per Share

₹ 33.96

Dividend Yield

1.97

Face Value

₹ 5.00

What’s Your Call?

Collective community sentiment on Anuh Pharma Ltd

Your Vote -

Buy

85.71%

Hold

9.52%

Sell

4.76%

85.71%

21 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

75.58

12

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

12

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anuh Pharma Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anuh Pharma - Updates

    22 May 2026, 7:14PM Anuh Pharma Limited has informed the Exchange regarding Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements

  • Anuh Pharma - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20

    22 May 2026, 7:10PM Intimation for the Resolution for reclassification of shareholders from Promoter group to Public category

  • Anuh Pharma - Copy of Newspaper Publication

    22 May 2026, 12:12PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication of the Audited financial results for the Quarter and year ended 31st

  • Anuh Pharma - Updates

    20 May 2026, 11:57PM Anuh Pharma Limited has informed the Exchange regarding 'Adoption For Policy For Implementation Of NFRA Circular'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Adoption For Policy For Implementation Of NFRA Circular

    20 May 2026, 11:55PM Adoption for policy for implementation of NFRA circular

  • Anuh Pharma - Updates

    20 May 2026, 11:53PM Anuh Pharma Limited has informed the Exchange regarding 'Appointment Of Scrutinizer For The 66Th Annual General Meeting.'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Appointment Of Scrutinizer For The 66Th Annual General Meeting.

    20 May 2026, 11:51PM Appointment of Scrutinizer for the 66th Annual General Meeting.

  • Anuh Pharma - Updates

    20 May 2026, 11:49PM Anuh Pharma Limited has informed the Exchange regarding '66Th Annual General Meeting Will Be Held On Wednesday, 12Th August, 2026.'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - 66Th Annual General Meeting Will Be Held On Wednesday, 12Th August, 2

    20 May 2026, 11:47PM 66th Annual General Meeting will be held on Wednesday, 12th August, 2026 through Video Conferencing and other audio visual means.

  • Anuh Pharma - Updates

    20 May 2026, 11:40PM Anuh Pharma Limited has informed the Exchange regarding 'Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirement

  • Anuh Pharma - Intimation Pursuant To Regulation 31A Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20

    20 May 2026, 11:38PM Intimation for re-classification of shareholders from Promoter group to public category

  • Anuh Pharma - Updates

    20 May 2026, 11:33PM Anuh Pharma Limited has informed the Exchange regarding 'Granting Authorization To Key Managerial Personnel For Determination Of Materiality Of Events

  • Anuh Pharma - Updates

    20 May 2026, 11:31PM Anuh Pharma Limited has informed the Exchange regarding 'Adoption of Memorandum of Association (MOA) and Articles of Association (AOA) as per Companie

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Granting Authorization To Key Managerial Personnel For Determination

    20 May 2026, 11:30PM Granting Authorization to Key Managerial Personnel for Determination of Materiality of Events.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Adoption Of Memorandum Of Association (MOA) And Articles Of Associati

    20 May 2026, 11:25PM Adoption of Memorandum of Association (MOA) and Articles of Association (AOA) as per Companies Act, 2013.

  • Anuh Pharma - Updates

    20 May 2026, 11:10PM Anuh Pharma Limited has informed the Exchange regarding 're-appointment of Cost Auditor.'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Re-Appointment Of Cost Auditor

    20 May 2026, 11:09PM Re-appointment of Cost Auditor

  • Anuh Pharma - Updates

    20 May 2026, 11:06PM Anuh Pharma Limited has informed the Exchange regarding 'appointment of Internal Auditor'.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Appointment Of Internal Auditor.

    20 May 2026, 11:05PM Appointment of Internal Auditor.

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Appointment Of Mr. P.N. Rao As General Manager - Quality

    20 May 2026, 11:03PM Appointment of Mr. P.N. Rao as General Manager - Quality.

  • Anuh Pharma - Updates

    20 May 2026, 10:59PM Anuh Pharma Limited has informed the Exchange regarding 'appointment of Mr. P. N. Rao as General Manager - Quality.'.

  • Anuh Pharma - Updates

    20 May 2026, 10:55PM Anuh Pharma Limited has informed the Exchange regarding 'Anuh Pharma Limited has informed the Exchange regarding intimation for re-appointment of dire

  • Anuh Pharma - Announcement under Regulation 30 (LODR)-Change in Management

    20 May 2026, 10:52PM Intimation for Re-appointment of Directors retiring by rotation.

  • Anuh Pharma - Corporate Action - Fixes Record Date For Dividend

    20 May 2026, 10:48PM The record date for dividend is fixed and is enclosed herewith

  • Anuh Pharma - Record Date

    20 May 2026, 10:46PM Anuh Pharma Limited has informed the Exchange that Record date for the purpose of Dividend is 05-Aug-2026.

  • Anuh Pharma - Dividend

    20 May 2026, 10:42PM Anuh Pharma Limited has informed the Exchange that Board of Directors at its meeting held on May 20, 2026, recommended Final Dividend of Rs. 1.50 per

  • Anuh Pharma - Corporate Action-Board approves Dividend

    20 May 2026, 10:39PM Final Dividend of Rs. 1.50 (30%) per equity shares of Face Value of Rs. 5 each for the Financial year ended 31/03/2026

  • Anuh Pharma - Updates

    20 May 2026, 10:28PM Anuh Pharma Limited has informed the Exchange regarding 'Financial Results'.

  • Anuh Pharma - Results - Financials Results For The Year Ended 31/03/2026

    20 May 2026, 10:17PM Financial Results for the Financial Year ended 31/03/2026

  • Anuh Pharma Q4 net profit down 6.26% at Rs 11.68 cr

    20 May 2026, 10:10PM The company reported standalone net profit of Rs 11.68 crore for the quarter ended March 31, 2026 as compared to Rs 12.46 crore in the same period las

  • Anuh Pharma - Board Meeting Outcome for Board Meeting Outcome For The Board Meeting Held On 20/05/2026

    20 May 2026, 9:57PM Consider and approve the Audited Financial Results for the Financial Year ending 31st March, 2026, and recommendation of Final Dividend for the Financ

  • Anuh Pharma - Outcome of Board Meeting

    20 May 2026, 9:47PM Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.

  • Anuh Pharma - Updates

    19 May 2026, 3:14PM Anuh Pharma Limited has informed the Exchange regarding Intimation for requests received from Persons belonging to Promoter Group seeking reclassifica

  • Anuh Pharma - Intimation Of Requests Received For Reclassification By Promoter Group To Public Under Regulation 31A Of SEBI (

    19 May 2026, 3:06PM Intimation for requests received from Persons belonging to Promoter Group seeking reclassification from Promoter Group to Public.

  • Anuh Pharma - Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Financ

    15 May 2026, 8:16PM Anuh Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and appr

  • Anuh Pharma - Updates

    4 May 2026, 9:40PM Anuh Pharma Limited has informed the Exchange regarding 'Approval from World Health Organization (WHO) Prequalification (WHO PQ) for Amodiaquine Hydro

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Updates

    4 May 2026, 9:37PM Approval from World Health Organization (WHO) Prequalification (WHO PQ) for Amodiaquine Hydrochloride USP

  • Anuh Pharma - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

    30 Apr 2026, 11:29AM <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border='1px'><tr> <td><b>Sr. No.</b></td

  • Anuh Pharma - Copy of Newspaper Publication

    28 Apr 2026, 12:26PM Anuh Pharma Limited has informed the Exchange about Copy of Newspaper Publication for Second 100 Days Campaign - ""Saksham Niveshak.""

  • Anuh Pharma has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    17 Apr 2026, 12:30PM As of March 2026, 71.80% is owned by Promoters and 28.20% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 71.78% and Fore

  • Anuh Pharma - Copy of Newspaper Publication

    17 Apr 2026, 11:45AM Anuh Pharma Limited has informed the Exchange about Newspaper Publication regarding notice to shareholders for Special Window for transfer and demater

  • Anuh Pharma - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Apr 2026, 5:25PM Anuh Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Anuh Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Apr 2026, 5:22PM Compliance Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2026 r

  • Anuh Pharma - Trading Window

    27 Mar 2026, 2:49PM Anuh Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

  • Anuh Pharma - Updates

    6 Mar 2026, 6:27PM Anuh Pharma Limited has informed the Exchange regarding Completion Of European Directorate For The Quality Of Medicines & Healthcare (EDQM) Audit And

  • Anuh Pharma - Announcement Under Regulation 30 (LODR) - Completion Of European Directorate For The Quality Of Medicines & Hea

    6 Mar 2026, 6:22PM Completion of European Directorate for the Quality of Medicines & Healthcare (EDQM) Audit and our facilities were found compliant under the Audit

  • Anuh Pharma gets nod from WHO

    29 Sep 2020 , 10:28AM Anuh Pharma Ltd receives approval from WHO for Pyrimcthamine API
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anuh Pharma Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 352.2224 336.5229 293.2313 241.2214 216.8838
Liabilities 352.2224 336.5229 293.2313 241.2214 216.8838
Equity 50.112 25.056 25.056 25.056 25.056
Gross Profit 61.7203 60.9087 75.1491 51.2745 46.8455
Net Profit 41.0461 47.3519 60.0575 36.1796 30.5613
Cash From Operating Activities -3.0116 37.1248 12.9251 53.9016 28.8637
NPM(%) 5.31 7.15 9.28 6.85 6.27
Revenue 771.6574 661.5149 647.0043 527.486 486.6462
Expenses 709.9371 600.6062 571.8552 476.2115 439.8007
ROE(%) 12.05 13.91 17.64 10.62 8.97

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
1.5 30 1.98 81.19
14 Aug 2025 1.5 30 1.98 207.39

Peers

Other companies within the same industry or sector that are comparable to Anuh Pharma Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 705.80 -0.07 0.00 43.44 -26.19 0.71
Lotus Eye Hospital and Institute Ltd 109.19 1.26 352.23 158.28 3.55 0.00
Vaishali Pharma Ltd 7.00 0.14 0.00 992.95 3.13 0.00
Astec Lifesciences Ltd 771.80 4.77 0.00 149.26 -363.15 0.00

Company Info

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1. 2025-The Company has issued Bonus Shares in the Ratio of 1:1.

1961 - Anuh Pharma Ltd was incorporated. 2006 - In early January, the promoters sold off nearly 14.9% of their stake in the company. -Anuh Pharma has given the Bonus in the Ratio of 1:1 -Company has splits its Face value of Shares from Rs 10 to Rs 5 2010 -Anuh Pharma has given the Bonus in the Ratio of 2:1 2011 -Anuh Pharma has recommended a Dividend of Rs. 5.00 per share of face value of Rs. 5.00. 2012 -Anuh Pharma Ltd has entered into a Memorandum of Understanding with M/s. Invent Pharma Pvt. Ltd., to acquire all fixed assets of their Research & Development Laboratory. -Anuh Pharma has recommended a dividend of Rs. 5.50 per equity share of face value of Rs. 5.00. 2013 -Anuh Pharma has recommended a dividend of Rs. 6.00 per equity share of face value of Rs. 5.00. 2014 -Anuh Pharma Ltd have received approval from COFEPRIS (Health Authority of Mexico) GMP certificate for three of Companys Erythromycin products namely Erythromycin Estolate, Erythromycin Ethyl Succinate & Erythromycin Stearate. -Anuh Pharma has recommended a Final Dividend of Rs. 6.50 (130%) per share. 2015 -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 2:1. 2016 -Anu Pharma Ltd has received EUGMP Certificate granted by ANSM - France. 2020 -The Company has issued Bonus Shares in the Ratio of 1:1. 2025-The Company has issued Bonus Shares in the Ratio of 1:1.

Parent Organisation

Anuh Pharma Ltd.

Founded

19/02/1960

Managing Director

Mr.Ritesh B Shah

NSE Symbol

ANUHPHREQ

FAQ

Invest Better, Trade Faster — Install Now.

Mirae Asset Sharekhan App

Recommended

Open App

Browser

Continue
OPEN FREE* DEMAT ACCOUNT